TCT 898: Successful Closure of Transcatheter Aortic Valve Replacement-Induced Gerbode Defect With Valve-in-Valve Technique: A Case Report Receive the the latest news, research, and presentations from ...
For the rising number of patients needing aortic reintervention, transcatheter aortic valve replacement (TAVR) explantation carried the highest mortality risk, two registry analyses affirmed. In ...
FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis early in the disease process while patients still had no symptoms or other ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Transcatheter aortic-valve replacement (TAVR) has revolutionized the treatment of symptomatic aortic stenosis, offering a less invasive alternative to surgery. This procedure was first used in ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. The study was aimed at investigating the mathematical relationship between the aortic valve and aortic ...
Six months after aortic valve replacement, many people can return to typical activities like exercising, socializing, and working. However, the recovery timeline can vary from person to person. One of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback